nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Urticaria—Estradiol—prostate cancer	0.000518	0.000518	CcSEcCtD
Verteporfin—Immune system disorder—Capecitabine—prostate cancer	0.000517	0.000517	CcSEcCtD
Verteporfin—Body temperature increased—Estradiol—prostate cancer	0.000515	0.000515	CcSEcCtD
Verteporfin—Headache—Goserelin—prostate cancer	0.000515	0.000515	CcSEcCtD
Verteporfin—Malnutrition—Docetaxel—prostate cancer	0.000514	0.000514	CcSEcCtD
Verteporfin—Rash—Conjugated Estrogens—prostate cancer	0.000514	0.000514	CcSEcCtD
Verteporfin—Dermatitis—Conjugated Estrogens—prostate cancer	0.000513	0.000513	CcSEcCtD
Verteporfin—Haemoglobin—Prednisone—prostate cancer	0.000512	0.000512	CcSEcCtD
Verteporfin—Headache—Conjugated Estrogens—prostate cancer	0.00051	0.00051	CcSEcCtD
Verteporfin—Haemorrhage—Prednisone—prostate cancer	0.00051	0.00051	CcSEcCtD
Verteporfin—Muscular weakness—Epirubicin—prostate cancer	0.000508	0.000508	CcSEcCtD
Verteporfin—Feeling abnormal—Mitoxantrone—prostate cancer	0.0005	0.0005	CcSEcCtD
Verteporfin—Blood creatinine increased—Doxorubicin—prostate cancer	0.000499	0.000499	CcSEcCtD
Verteporfin—Malnutrition—Capecitabine—prostate cancer	0.000498	0.000498	CcSEcCtD
Verteporfin—Influenza—Epirubicin—prostate cancer	0.000498	0.000498	CcSEcCtD
Verteporfin—Back pain—Docetaxel—prostate cancer	0.000498	0.000498	CcSEcCtD
Verteporfin—Liver function test abnormal—Doxorubicin—prostate cancer	0.000492	0.000492	CcSEcCtD
Verteporfin—Skin disorder—Etoposide—prostate cancer	0.000491	0.000491	CcSEcCtD
Verteporfin—Nausea—Goserelin—prostate cancer	0.000488	0.000488	CcSEcCtD
Verteporfin—Hyperhidrosis—Etoposide—prostate cancer	0.000488	0.000488	CcSEcCtD
Verteporfin—Nausea—Conjugated Estrogens—prostate cancer	0.000484	0.000484	CcSEcCtD
Verteporfin—Urticaria—Mitoxantrone—prostate cancer	0.000482	0.000482	CcSEcCtD
Verteporfin—Back pain—Capecitabine—prostate cancer	0.000482	0.000482	CcSEcCtD
Verteporfin—Hypersensitivity—Estradiol—prostate cancer	0.00048	0.00048	CcSEcCtD
Verteporfin—Body temperature increased—Mitoxantrone—prostate cancer	0.00048	0.00048	CcSEcCtD
Verteporfin—Eye disorder—Prednisone—prostate cancer	0.000476	0.000476	CcSEcCtD
Verteporfin—Anaemia—Docetaxel—prostate cancer	0.000475	0.000475	CcSEcCtD
Verteporfin—Flushing—Prednisone—prostate cancer	0.000473	0.000473	CcSEcCtD
Verteporfin—Muscular weakness—Doxorubicin—prostate cancer	0.00047	0.00047	CcSEcCtD
Verteporfin—Vision blurred—Capecitabine—prostate cancer	0.000469	0.000469	CcSEcCtD
Verteporfin—Asthenia—Estradiol—prostate cancer	0.000468	0.000468	CcSEcCtD
Verteporfin—Angiopathy—Prednisone—prostate cancer	0.000462	0.000462	CcSEcCtD
Verteporfin—Ill-defined disorder—Capecitabine—prostate cancer	0.000462	0.000462	CcSEcCtD
Verteporfin—Syncope—Docetaxel—prostate cancer	0.000461	0.000461	CcSEcCtD
Verteporfin—Pruritus—Estradiol—prostate cancer	0.000461	0.000461	CcSEcCtD
Verteporfin—Influenza—Doxorubicin—prostate cancer	0.000461	0.000461	CcSEcCtD
Verteporfin—Anaemia—Capecitabine—prostate cancer	0.00046	0.00046	CcSEcCtD
Verteporfin—Immune system disorder—Prednisone—prostate cancer	0.00046	0.00046	CcSEcCtD
Verteporfin—Photosensitivity reaction—Epirubicin—prostate cancer	0.000455	0.000455	CcSEcCtD
Verteporfin—Loss of consciousness—Docetaxel—prostate cancer	0.000452	0.000452	CcSEcCtD
Verteporfin—Dyspnoea—Etoposide—prostate cancer	0.00045	0.00045	CcSEcCtD
Verteporfin—Malaise—Capecitabine—prostate cancer	0.000449	0.000449	CcSEcCtD
Verteporfin—Cough—Docetaxel—prostate cancer	0.000449	0.000449	CcSEcCtD
Verteporfin—Vertigo—Capecitabine—prostate cancer	0.000447	0.000447	CcSEcCtD
Verteporfin—Hypersensitivity—Mitoxantrone—prostate cancer	0.000447	0.000447	CcSEcCtD
Verteporfin—Syncope—Capecitabine—prostate cancer	0.000447	0.000447	CcSEcCtD
Verteporfin—Pneumonia—Epirubicin—prostate cancer	0.000447	0.000447	CcSEcCtD
Verteporfin—Hypertension—Docetaxel—prostate cancer	0.000444	0.000444	CcSEcCtD
Verteporfin—Malnutrition—Prednisone—prostate cancer	0.000444	0.000444	CcSEcCtD
Verteporfin—Arthralgia—Docetaxel—prostate cancer	0.000438	0.000438	CcSEcCtD
Verteporfin—Chest pain—Docetaxel—prostate cancer	0.000438	0.000438	CcSEcCtD
Verteporfin—Loss of consciousness—Capecitabine—prostate cancer	0.000438	0.000438	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Etoposide—prostate cancer	0.000436	0.000436	CcSEcCtD
Verteporfin—Asthenia—Mitoxantrone—prostate cancer	0.000436	0.000436	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000435	0.000435	CcSEcCtD
Verteporfin—Cough—Capecitabine—prostate cancer	0.000435	0.000435	CcSEcCtD
Verteporfin—Pain—Etoposide—prostate cancer	0.000432	0.000432	CcSEcCtD
Verteporfin—Constipation—Etoposide—prostate cancer	0.000432	0.000432	CcSEcCtD
Verteporfin—Conjunctivitis—Epirubicin—prostate cancer	0.000432	0.000432	CcSEcCtD
Verteporfin—Dizziness—Estradiol—prostate cancer	0.000431	0.000431	CcSEcCtD
Verteporfin—Hypertension—Capecitabine—prostate cancer	0.00043	0.00043	CcSEcCtD
Verteporfin—Sweating—Epirubicin—prostate cancer	0.000426	0.000426	CcSEcCtD
Verteporfin—Arthralgia—Capecitabine—prostate cancer	0.000424	0.000424	CcSEcCtD
Verteporfin—Chest pain—Capecitabine—prostate cancer	0.000424	0.000424	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000421	0.000421	CcSEcCtD
Verteporfin—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000421	0.000421	CcSEcCtD
Verteporfin—Oedema—Docetaxel—prostate cancer	0.00042	0.00042	CcSEcCtD
Verteporfin—Discomfort—Capecitabine—prostate cancer	0.000419	0.000419	CcSEcCtD
Verteporfin—Vision blurred—Prednisone—prostate cancer	0.000418	0.000418	CcSEcCtD
Verteporfin—Feeling abnormal—Etoposide—prostate cancer	0.000416	0.000416	CcSEcCtD
Verteporfin—Pneumonia—Doxorubicin—prostate cancer	0.000413	0.000413	CcSEcCtD
Verteporfin—Shock—Docetaxel—prostate cancer	0.000413	0.000413	CcSEcCtD
Verteporfin—Nervous system disorder—Docetaxel—prostate cancer	0.000412	0.000412	CcSEcCtD
Verteporfin—Ill-defined disorder—Prednisone—prostate cancer	0.000412	0.000412	CcSEcCtD
Verteporfin—Rash—Estradiol—prostate cancer	0.000411	0.000411	CcSEcCtD
Verteporfin—Dermatitis—Estradiol—prostate cancer	0.000411	0.000411	CcSEcCtD
Verteporfin—Anaemia—Prednisone—prostate cancer	0.00041	0.00041	CcSEcCtD
Verteporfin—Headache—Estradiol—prostate cancer	0.000408	0.000408	CcSEcCtD
Verteporfin—Skin disorder—Docetaxel—prostate cancer	0.000408	0.000408	CcSEcCtD
Verteporfin—Oedema—Capecitabine—prostate cancer	0.000406	0.000406	CcSEcCtD
Verteporfin—Urticaria—Etoposide—prostate cancer	0.000401	0.000401	CcSEcCtD
Verteporfin—Haemoglobin—Epirubicin—prostate cancer	0.000401	0.000401	CcSEcCtD
Verteporfin—Malaise—Prednisone—prostate cancer	0.0004	0.0004	CcSEcCtD
Verteporfin—Shock—Capecitabine—prostate cancer	0.0004	0.0004	CcSEcCtD
Verteporfin—Body temperature increased—Etoposide—prostate cancer	0.000399	0.000399	CcSEcCtD
Verteporfin—Conjunctivitis—Doxorubicin—prostate cancer	0.000399	0.000399	CcSEcCtD
Verteporfin—Nervous system disorder—Capecitabine—prostate cancer	0.000399	0.000399	CcSEcCtD
Verteporfin—Vertigo—Prednisone—prostate cancer	0.000399	0.000399	CcSEcCtD
Verteporfin—Haemorrhage—Epirubicin—prostate cancer	0.000399	0.000399	CcSEcCtD
Verteporfin—Syncope—Prednisone—prostate cancer	0.000398	0.000398	CcSEcCtD
Verteporfin—Hypoaesthesia—Epirubicin—prostate cancer	0.000397	0.000397	CcSEcCtD
Verteporfin—Pharyngitis—Epirubicin—prostate cancer	0.000396	0.000396	CcSEcCtD
Verteporfin—Skin disorder—Capecitabine—prostate cancer	0.000395	0.000395	CcSEcCtD
Verteporfin—Sweating—Doxorubicin—prostate cancer	0.000394	0.000394	CcSEcCtD
Verteporfin—Hyperhidrosis—Capecitabine—prostate cancer	0.000393	0.000393	CcSEcCtD
Verteporfin—Loss of consciousness—Prednisone—prostate cancer	0.00039	0.00039	CcSEcCtD
Verteporfin—Nausea—Estradiol—prostate cancer	0.000387	0.000387	CcSEcCtD
Verteporfin—Visual impairment—Epirubicin—prostate cancer	0.000384	0.000384	CcSEcCtD
Verteporfin—Hypertension—Prednisone—prostate cancer	0.000383	0.000383	CcSEcCtD
Verteporfin—Rash—Mitoxantrone—prostate cancer	0.000383	0.000383	CcSEcCtD
Verteporfin—Dermatitis—Mitoxantrone—prostate cancer	0.000383	0.000383	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000383	0.000383	CcSEcCtD
Verteporfin—Headache—Mitoxantrone—prostate cancer	0.00038	0.00038	CcSEcCtD
Verteporfin—Arthralgia—Prednisone—prostate cancer	0.000378	0.000378	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000375	0.000375	CcSEcCtD
Verteporfin—Dyspnoea—Docetaxel—prostate cancer	0.000374	0.000374	CcSEcCtD
Verteporfin—Discomfort—Prednisone—prostate cancer	0.000373	0.000373	CcSEcCtD
Verteporfin—Eye disorder—Epirubicin—prostate cancer	0.000372	0.000372	CcSEcCtD
Verteporfin—Hypersensitivity—Etoposide—prostate cancer	0.000372	0.000372	CcSEcCtD
Verteporfin—Haemoglobin—Doxorubicin—prostate cancer	0.000371	0.000371	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.00037	0.00037	CcSEcCtD
Verteporfin—Cardiac disorder—Epirubicin—prostate cancer	0.00037	0.00037	CcSEcCtD
Verteporfin—Flushing—Epirubicin—prostate cancer	0.00037	0.00037	CcSEcCtD
Verteporfin—Haemorrhage—Doxorubicin—prostate cancer	0.000369	0.000369	CcSEcCtD
Verteporfin—Hypoaesthesia—Doxorubicin—prostate cancer	0.000367	0.000367	CcSEcCtD
Verteporfin—Pharyngitis—Doxorubicin—prostate cancer	0.000366	0.000366	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000362	0.000362	CcSEcCtD
Verteporfin—Asthenia—Etoposide—prostate cancer	0.000362	0.000362	CcSEcCtD
Verteporfin—Dyspnoea—Capecitabine—prostate cancer	0.000362	0.000362	CcSEcCtD
Verteporfin—Oedema—Prednisone—prostate cancer	0.000362	0.000362	CcSEcCtD
Verteporfin—Angiopathy—Epirubicin—prostate cancer	0.000362	0.000362	CcSEcCtD
Verteporfin—Nausea—Mitoxantrone—prostate cancer	0.000361	0.000361	CcSEcCtD
Verteporfin—Immune system disorder—Epirubicin—prostate cancer	0.00036	0.00036	CcSEcCtD
Verteporfin—Constipation—Docetaxel—prostate cancer	0.000359	0.000359	CcSEcCtD
Verteporfin—Pain—Docetaxel—prostate cancer	0.000359	0.000359	CcSEcCtD
Verteporfin—Pruritus—Etoposide—prostate cancer	0.000357	0.000357	CcSEcCtD
Verteporfin—Shock—Prednisone—prostate cancer	0.000356	0.000356	CcSEcCtD
Verteporfin—Visual impairment—Doxorubicin—prostate cancer	0.000355	0.000355	CcSEcCtD
Verteporfin—Nervous system disorder—Prednisone—prostate cancer	0.000355	0.000355	CcSEcCtD
Verteporfin—Skin disorder—Prednisone—prostate cancer	0.000352	0.000352	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000351	0.000351	CcSEcCtD
Verteporfin—Hyperhidrosis—Prednisone—prostate cancer	0.00035	0.00035	CcSEcCtD
Verteporfin—Pain—Capecitabine—prostate cancer	0.000348	0.000348	CcSEcCtD
Verteporfin—Constipation—Capecitabine—prostate cancer	0.000348	0.000348	CcSEcCtD
Verteporfin—Malnutrition—Epirubicin—prostate cancer	0.000347	0.000347	CcSEcCtD
Verteporfin—Feeling abnormal—Docetaxel—prostate cancer	0.000346	0.000346	CcSEcCtD
Verteporfin—Eye disorder—Doxorubicin—prostate cancer	0.000345	0.000345	CcSEcCtD
Verteporfin—Cardiac disorder—Doxorubicin—prostate cancer	0.000342	0.000342	CcSEcCtD
Verteporfin—Flushing—Doxorubicin—prostate cancer	0.000342	0.000342	CcSEcCtD
Verteporfin—Back pain—Epirubicin—prostate cancer	0.000336	0.000336	CcSEcCtD
Verteporfin—Feeling abnormal—Capecitabine—prostate cancer	0.000335	0.000335	CcSEcCtD
Verteporfin—Angiopathy—Doxorubicin—prostate cancer	0.000335	0.000335	CcSEcCtD
Verteporfin—Dizziness—Etoposide—prostate cancer	0.000334	0.000334	CcSEcCtD
Verteporfin—Immune system disorder—Doxorubicin—prostate cancer	0.000333	0.000333	CcSEcCtD
Verteporfin—Body temperature increased—Docetaxel—prostate cancer	0.000332	0.000332	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Prednisone—prostate cancer	0.00033	0.00033	CcSEcCtD
Verteporfin—Vision blurred—Epirubicin—prostate cancer	0.000327	0.000327	CcSEcCtD
Verteporfin—Urticaria—Capecitabine—prostate cancer	0.000323	0.000323	CcSEcCtD
Verteporfin—Ill-defined disorder—Epirubicin—prostate cancer	0.000322	0.000322	CcSEcCtD
Verteporfin—Body temperature increased—Capecitabine—prostate cancer	0.000321	0.000321	CcSEcCtD
Verteporfin—Malnutrition—Doxorubicin—prostate cancer	0.000321	0.000321	CcSEcCtD
Verteporfin—Anaemia—Epirubicin—prostate cancer	0.000321	0.000321	CcSEcCtD
Verteporfin—Rash—Etoposide—prostate cancer	0.000319	0.000319	CcSEcCtD
Verteporfin—Dermatitis—Etoposide—prostate cancer	0.000318	0.000318	CcSEcCtD
Verteporfin—Headache—Etoposide—prostate cancer	0.000316	0.000316	CcSEcCtD
Verteporfin—Malaise—Epirubicin—prostate cancer	0.000313	0.000313	CcSEcCtD
Verteporfin—Vertigo—Epirubicin—prostate cancer	0.000312	0.000312	CcSEcCtD
Verteporfin—Syncope—Epirubicin—prostate cancer	0.000311	0.000311	CcSEcCtD
Verteporfin—Back pain—Doxorubicin—prostate cancer	0.000311	0.000311	CcSEcCtD
Verteporfin—Constipation—Prednisone—prostate cancer	0.00031	0.00031	CcSEcCtD
Verteporfin—Hypersensitivity—Docetaxel—prostate cancer	0.000309	0.000309	CcSEcCtD
Verteporfin—Loss of consciousness—Epirubicin—prostate cancer	0.000305	0.000305	CcSEcCtD
Verteporfin—Cough—Epirubicin—prostate cancer	0.000303	0.000303	CcSEcCtD
Verteporfin—Vision blurred—Doxorubicin—prostate cancer	0.000303	0.000303	CcSEcCtD
Verteporfin—Asthenia—Docetaxel—prostate cancer	0.000301	0.000301	CcSEcCtD
Verteporfin—Nausea—Etoposide—prostate cancer	0.0003	0.0003	CcSEcCtD
Verteporfin—Hypertension—Epirubicin—prostate cancer	0.0003	0.0003	CcSEcCtD
Verteporfin—Hypersensitivity—Capecitabine—prostate cancer	0.000299	0.000299	CcSEcCtD
Verteporfin—Feeling abnormal—Prednisone—prostate cancer	0.000298	0.000298	CcSEcCtD
Verteporfin—Ill-defined disorder—Doxorubicin—prostate cancer	0.000298	0.000298	CcSEcCtD
Verteporfin—Pruritus—Docetaxel—prostate cancer	0.000297	0.000297	CcSEcCtD
Verteporfin—Anaemia—Doxorubicin—prostate cancer	0.000297	0.000297	CcSEcCtD
Verteporfin—Arthralgia—Epirubicin—prostate cancer	0.000295	0.000295	CcSEcCtD
Verteporfin—Chest pain—Epirubicin—prostate cancer	0.000295	0.000295	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000293	0.000293	CcSEcCtD
Verteporfin—Discomfort—Epirubicin—prostate cancer	0.000292	0.000292	CcSEcCtD
Verteporfin—Asthenia—Capecitabine—prostate cancer	0.000292	0.000292	CcSEcCtD
Verteporfin—Malaise—Doxorubicin—prostate cancer	0.00029	0.00029	CcSEcCtD
Verteporfin—Vertigo—Doxorubicin—prostate cancer	0.000288	0.000288	CcSEcCtD
Verteporfin—Syncope—Doxorubicin—prostate cancer	0.000288	0.000288	CcSEcCtD
Verteporfin—Urticaria—Prednisone—prostate cancer	0.000288	0.000288	CcSEcCtD
Verteporfin—Pruritus—Capecitabine—prostate cancer	0.000288	0.000288	CcSEcCtD
Verteporfin—Body temperature increased—Prednisone—prostate cancer	0.000286	0.000286	CcSEcCtD
Verteporfin—Oedema—Epirubicin—prostate cancer	0.000283	0.000283	CcSEcCtD
Verteporfin—Loss of consciousness—Doxorubicin—prostate cancer	0.000282	0.000282	CcSEcCtD
Verteporfin—Cough—Doxorubicin—prostate cancer	0.00028	0.00028	CcSEcCtD
Verteporfin—Shock—Epirubicin—prostate cancer	0.000279	0.000279	CcSEcCtD
Verteporfin—Nervous system disorder—Epirubicin—prostate cancer	0.000278	0.000278	CcSEcCtD
Verteporfin—Dizziness—Docetaxel—prostate cancer	0.000278	0.000278	CcSEcCtD
Verteporfin—Hypertension—Doxorubicin—prostate cancer	0.000277	0.000277	CcSEcCtD
Verteporfin—Skin disorder—Epirubicin—prostate cancer	0.000275	0.000275	CcSEcCtD
Verteporfin—Hyperhidrosis—Epirubicin—prostate cancer	0.000274	0.000274	CcSEcCtD
Verteporfin—Arthralgia—Doxorubicin—prostate cancer	0.000273	0.000273	CcSEcCtD
Verteporfin—Chest pain—Doxorubicin—prostate cancer	0.000273	0.000273	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000271	0.000271	CcSEcCtD
Verteporfin—Discomfort—Doxorubicin—prostate cancer	0.00027	0.00027	CcSEcCtD
Verteporfin—Dizziness—Capecitabine—prostate cancer	0.000269	0.000269	CcSEcCtD
Verteporfin—Hypersensitivity—Prednisone—prostate cancer	0.000267	0.000267	CcSEcCtD
Verteporfin—Rash—Docetaxel—prostate cancer	0.000265	0.000265	CcSEcCtD
Verteporfin—Dermatitis—Docetaxel—prostate cancer	0.000264	0.000264	CcSEcCtD
Verteporfin—Headache—Docetaxel—prostate cancer	0.000263	0.000263	CcSEcCtD
Verteporfin—Oedema—Doxorubicin—prostate cancer	0.000262	0.000262	CcSEcCtD
Verteporfin—Asthenia—Prednisone—prostate cancer	0.00026	0.00026	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000258	0.000258	CcSEcCtD
Verteporfin—Shock—Doxorubicin—prostate cancer	0.000258	0.000258	CcSEcCtD
Verteporfin—Nervous system disorder—Doxorubicin—prostate cancer	0.000257	0.000257	CcSEcCtD
Verteporfin—Rash—Capecitabine—prostate cancer	0.000256	0.000256	CcSEcCtD
Verteporfin—Pruritus—Prednisone—prostate cancer	0.000256	0.000256	CcSEcCtD
Verteporfin—Dermatitis—Capecitabine—prostate cancer	0.000256	0.000256	CcSEcCtD
Verteporfin—Headache—Capecitabine—prostate cancer	0.000255	0.000255	CcSEcCtD
Verteporfin—Skin disorder—Doxorubicin—prostate cancer	0.000255	0.000255	CcSEcCtD
Verteporfin—Hyperhidrosis—Doxorubicin—prostate cancer	0.000253	0.000253	CcSEcCtD
Verteporfin—Dyspnoea—Epirubicin—prostate cancer	0.000252	0.000252	CcSEcCtD
Verteporfin—Nausea—Docetaxel—prostate cancer	0.000249	0.000249	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000244	0.000244	CcSEcCtD
Verteporfin—Pain—Epirubicin—prostate cancer	0.000242	0.000242	CcSEcCtD
Verteporfin—Constipation—Epirubicin—prostate cancer	0.000242	0.000242	CcSEcCtD
Verteporfin—Nausea—Capecitabine—prostate cancer	0.000241	0.000241	CcSEcCtD
Verteporfin—Dizziness—Prednisone—prostate cancer	0.000239	0.000239	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000239	0.000239	CcSEcCtD
Verteporfin—Dyspnoea—Doxorubicin—prostate cancer	0.000234	0.000234	CcSEcCtD
Verteporfin—Feeling abnormal—Epirubicin—prostate cancer	0.000233	0.000233	CcSEcCtD
Verteporfin—Rash—Prednisone—prostate cancer	0.000228	0.000228	CcSEcCtD
Verteporfin—Dermatitis—Prednisone—prostate cancer	0.000228	0.000228	CcSEcCtD
Verteporfin—Headache—Prednisone—prostate cancer	0.000227	0.000227	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000226	0.000226	CcSEcCtD
Verteporfin—Urticaria—Epirubicin—prostate cancer	0.000225	0.000225	CcSEcCtD
Verteporfin—Constipation—Doxorubicin—prostate cancer	0.000224	0.000224	CcSEcCtD
Verteporfin—Pain—Doxorubicin—prostate cancer	0.000224	0.000224	CcSEcCtD
Verteporfin—Body temperature increased—Epirubicin—prostate cancer	0.000224	0.000224	CcSEcCtD
Verteporfin—Feeling abnormal—Doxorubicin—prostate cancer	0.000216	0.000216	CcSEcCtD
Verteporfin—Nausea—Prednisone—prostate cancer	0.000215	0.000215	CcSEcCtD
Verteporfin—Hypersensitivity—Epirubicin—prostate cancer	0.000209	0.000209	CcSEcCtD
Verteporfin—Urticaria—Doxorubicin—prostate cancer	0.000208	0.000208	CcSEcCtD
Verteporfin—Body temperature increased—Doxorubicin—prostate cancer	0.000207	0.000207	CcSEcCtD
Verteporfin—Asthenia—Epirubicin—prostate cancer	0.000203	0.000203	CcSEcCtD
Verteporfin—Pruritus—Epirubicin—prostate cancer	0.0002	0.0002	CcSEcCtD
Verteporfin—Hypersensitivity—Doxorubicin—prostate cancer	0.000193	0.000193	CcSEcCtD
Verteporfin—Asthenia—Doxorubicin—prostate cancer	0.000188	0.000188	CcSEcCtD
Verteporfin—Dizziness—Epirubicin—prostate cancer	0.000187	0.000187	CcSEcCtD
Verteporfin—Pruritus—Doxorubicin—prostate cancer	0.000185	0.000185	CcSEcCtD
Verteporfin—Rash—Epirubicin—prostate cancer	0.000179	0.000179	CcSEcCtD
Verteporfin—Dermatitis—Epirubicin—prostate cancer	0.000178	0.000178	CcSEcCtD
Verteporfin—Headache—Epirubicin—prostate cancer	0.000177	0.000177	CcSEcCtD
Verteporfin—Dizziness—Doxorubicin—prostate cancer	0.000173	0.000173	CcSEcCtD
Verteporfin—Nausea—Epirubicin—prostate cancer	0.000168	0.000168	CcSEcCtD
Verteporfin—Rash—Doxorubicin—prostate cancer	0.000165	0.000165	CcSEcCtD
Verteporfin—Dermatitis—Doxorubicin—prostate cancer	0.000165	0.000165	CcSEcCtD
Verteporfin—Headache—Doxorubicin—prostate cancer	0.000164	0.000164	CcSEcCtD
Verteporfin—Nausea—Doxorubicin—prostate cancer	0.000156	0.000156	CcSEcCtD
